Xvivo Perfusion AB (XVIVO) — Working Capital to Net Assets Ratio
Xvivo Perfusion AB (XVIVO) has a Working Capital to Net Assets ratio of 26.0% as of March 2026. Working capital of Skr564.32 Million (current assets of Skr724.69 Million minus current liabilities of Skr160.36 Million) is measured against net assets of Skr2.17 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of Xvivo Perfusion AB to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Xvivo Perfusion AB Working Capital to Net Assets (2012–2025)
This chart shows how Xvivo Perfusion AB's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the ratio stands at 26.0%, reflecting working capital of Skr564.32 Million against net assets of Skr2.17 Billion SEK. Check tangible net worth ratio of Xvivo Perfusion AB to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Xvivo Perfusion AB (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Xvivo Perfusion AB from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Xvivo Perfusion AB stock valuation.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 26.9% | Skr568.83 Million | Skr2.11 Billion | Skr688.21 Million | Skr119.38 Million | ▼ -2.6 pp |
| 2024 | 29.5% | Skr635.57 Million | Skr2.16 Billion | Skr813.08 Million | Skr177.51 Million | ▼ -6.1 pp |
| 2023 | 35.6% | Skr691.92 Million | Skr1.95 Billion | Skr826.40 Million | Skr134.49 Million | ▲ +12.3 pp |
| 2022 | 23.3% | Skr332.61 Million | Skr1.43 Billion | Skr467.51 Million | Skr134.90 Million | ▼ -11.2 pp |
| 2021 | 34.5% | Skr443.01 Million | Skr1.29 Billion | Skr547.53 Million | Skr104.52 Million | ▼ -4.3 pp |
| 2020 | 38.8% | Skr390.98 Million | Skr1.01 Billion | Skr463.23 Million | Skr72.25 Million | ▲ +2.9 pp |
| 2019 | 35.9% | Skr207.29 Million | Skr577.52 Million | Skr259.88 Million | Skr52.60 Million | ▼ -7.6 pp |
| 2018 | 43.5% | Skr235.11 Million | Skr540.48 Million | Skr277.68 Million | Skr42.57 Million | ▼ -2.8 pp |
| 2017 | 46.3% | Skr233.73 Million | Skr504.33 Million | Skr264.62 Million | Skr30.90 Million | ▲ +24.8 pp |
| 2016 | 21.6% | Skr68.27 Million | Skr316.41 Million | Skr98.11 Million | Skr29.84 Million | ▼ -21.7 pp |
| 2015 | 43.3% | Skr80.05 Million | Skr184.87 Million | Skr95.64 Million | Skr15.58 Million | ▲ +1.1 pp |
| 2014 | 42.2% | Skr74.38 Million | Skr176.18 Million | Skr93.14 Million | Skr18.76 Million | ▲ +34.6 pp |
| 2013 | 7.6% | Skr7.36 Million | Skr96.64 Million | Skr33.02 Million | Skr25.66 Million | ▼ -2.0 pp |
| 2012 | 9.7% | Skr8.57 Million | Skr88.77 Million | Skr32.29 Million | Skr23.72 Million | — |